| Wed, Nov 18, 2009 | | • | NicOx announces FDA accepts naproxcinod NDA for filing
Marketwire (Wed, Nov 18)
| | Fri, Nov 13, 2009 | | • | NicOx announces NCX 6560 meets primary and secondary objectives in first-in- man study
Marketwire (Fri, Nov 13)
| | Thu, Oct 22, 2009 | | • | Q3 2009 NicOx Earnings Release - 01:00 am ET
CCBN (Thu, Oct 22)
| | • | Report of NicOx's financial results for the first three quarters of 2009
Marketwire (Thu, Oct 22)
| | Tue, Oct 20, 2009 | | • | NicOx presents 26 week naproxcinod efficacy data at American College of Rheumatology
Marketwire (Tue, Oct 20)
| | Fri, Sep 25, 2009 | | • | NicOx submits New Drug Application (NDA) for naproxcinod to the US FDA
Marketwire (Fri, Sep 25)
| | Tue, Sep 22, 2009 | | • | Important data for NicOx' naproxcinod published in the American Journal of Cardiology
Marketwire (Tue, Sep 22)
| | Mon, Sep 14, 2009 | | • | NicOx makes three scientific presentations at the 2009 World Congress on Osteoarthritis
Marketwire (Mon, Sep 14)
| | Thu, Aug 6, 2009 | | • | NicOx reacquires rights to PF-03187207 for glaucoma from Pfizer
Marketwire (Thu, Aug 6)
| | Wed, Jul 29, 2009 | | • | NicOx first half 2009 financial results: naproxcinod nearing regulatory submissions in US and Europe
Marketwire (Wed, Jul 29)
| | Mon, Jun 15, 2009 | | • | NicOx: additional 24 hour blood pressure results for naproxcinod presented at the European Meeting on Hypertension
Marketwire (Mon, Jun 15)
| | Fri, Jun 12, 2009 | | • | NicOx presents naproxcinod results in several posters at EULAR
Marketwire (Fri, Jun 12)
| | Tue, Jun 9, 2009 | | • | NicOx publishes results of the ZEST phase 2 study for naproxcinod
Marketwire (Tue, Jun 9)
| | Tue, May 19, 2009 | | • | NicOx presents phase 3 quality of life data for naproxcinod at ISPOR
Marketwire (Tue, May 19)
| | Wed, May 13, 2009 | | • | NicOx reports first quarter 2009 financial results
Marketwire (Wed, May 13)
| | Thu, May 7, 2009 | | • | Analyses of phase 3 blood pressure data for NicOx' naproxcinod presented at ASH
Marketwire (Thu, May 7)
| | • | Analyses of phase 3 blood pressure data for NicOx' naproxcinod presented at ASH
Marketwire (Thu, May 7)
| | Tue, May 5, 2009 | | • | NicOx co-presents four posters on PF 03187207 for glaucoma at ARVO with Pfizer Inc
Marketwire (Tue, May 5)
| | Thu, Apr 23, 2009 | | • | NicOx acquires Nitromed's NO-donating patents
Marketwire (Thu, Apr 23)
| | Tue, Mar 31, 2009 | | • | New analyses of phase 3 data for NicOx' naproxcinod presented at the American College of Cardiology (ACC) Annual Meeting
Marketwire (Tue, Mar 31)
|
Add COX.PA News to My Yahoo!:
 
| |
|
0.63% Nasdaq 
0.03%
Headlines
